To quote veteran science writer Ed Yong's simple yet extremely accurate words in The Atlantic, "The immune system is very complicated." As the COVID-19 pandemic had made abundantly clear, science still doesn't fully understand ...
Mar 15, 2022
0
218
The level of expression of three genes associated with aging can be used to predict whether seemingly low-risk prostate cancer will remain slow-growing, according to researchers at the Herbert Irving Comprehensive Cancer ...
Sep 11, 2013
0
0
Ask any neurologist: Parkinson's disease is a brain disorder. The conspicuous symptoms of Parkinson's disease—uncontrollable tremors, slowed down motions, and the feeling that one's feet are stuck to the ground—all stem ...
Aug 21, 2023
0
316
Immune system abnormalities that mimic those seen with autism spectrum disorders have been linked to the amyloid precursor protein (APP), reports a research team from the University of South Florida's Department of Psychiatry ...
Jan 3, 2012
0
0
Medical investigators are theorizing that a combination of two treatments that activate myeloid cells may effectively treat a recalcitrant form of pancreatic cancer that thwarts conventional immunotherapy.
A key transcription factor in T-cell immunology is crucial to the immune system's "memory" in recognizing threats it has already faced before—and it may be possible to improve this immunological memory in vaccines, according ...
Feb 23, 2022
0
140
A groundbreaking study in the journal Nature Medicine suggests what could become the first effective treatment for a debilitating and fatal disease of the central nervous system called SCA1.
Oct 16, 2011
0
0
(Medical Xpress)—Scientists at Emory University School of Medicine have identified a compound that boosts levels of a survival factor in neurons threatened by Parkinson's disease.
Sep 5, 2012
0
0
She's a biologist investigating microbial genomics. He studies protein structures using electron microscopy. Put them together and their research opens doors.
Jun 6, 2011
0
0
A team of researchers from University Hospital Zurich and the University of Zurich, the Swiss Federal Institute of Technology and biotechnology company Philochem, has found fusing cytokines with antibodies to be an effective ...
